Advanced search×

Successful use of botulinum toxin type a in the treatment of refractory postoperative dyspareunia.

Park

Obstet Gynecol 114(2):484-7 (2009) PMID 19622971

Refractory dyspareunia presents a challenging therapeutic dilemma.

DOI: 10.1097/AOG.0b013e3181998ce1
Version: za2963e q8za7 q8zbf q8zc2 q8zda q8ze2 q8zf5 q8zg1

Similar articles you may find interesting…

  1. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to serotype B: tyrosine-1186 and lysine-1191 cause its lower affinity.
    Gesche Willjes, Stefan Mahrhold, and Thomas Binz

    Biochemistry (2013) PMID 23647335

    We systematically mutated the synaptotagmin binding site in BoNT/G and performed a comparative binding analysis with mutants of the cell binding subunit of BoNT/B. The results suggest that synaptotagmin takes the same overall orientation in BoNT/B and BoNT/G governed by the strictly conserved centra...
  2. C1 inhibitor concentrate treatment of multiple laryngeal attacks in a 53-year-old woman with hereditary angioedema.
    Flint R Packer

    Immunotherapy (2013) PMID 23647478

    This report describes a woman who experienced a high number of laryngeal hereditary angioedema (HAE) attacks during her participation in the IMPACT2 clinical trial of C1-INH concentrate. A 53-year-old caucasian female with a 31-year history of type 1 HAE experienced 16 laryngeal HAE...
  3. Lasers and lights for the treatment of striae distensae.
    J A Savas, J A Ledon, and K Nouri

    Lasers Med Sci (2013) PMID 23649615

    Striae distensae (SD) or "stretch marks" are a common and well-recognized dermatologic entity affecting patients of all ages, genders, and ethnicities. The treatment of SD has long been plagued by disappointing outcomes and remains a frustrating entity for both physicians and patient...